Seminars in Nephrology
Volume 24, Issue 5 , Pages 403-407 , September 2004

Arterial calcification in chronic kidney disease

  • Steven K. Burke

      Affiliations

    • Genzyme Drug Discovery and Development, Waltham, MA, USA
    • Corresponding Author InformationAddress reprint requests to Steven K. Burke, MD, Senior Vice President, Genzyme Drug Discovery and Development, 153 Second Ave, Waltham, MA 02451

References 

  1. Foley RN , Parfrey PS , Sarnak MJ . Clinical epidemiology of cardiovascular disease in chronic renal disease . Am J Kidney Dis . 1998;32:S112–S119
  2. Collins AJ , Li S , Ma JZ , et al.   Cardiovascular disease in end-stage renal disease patients . Am J Kidney Dis . 2001;38:S26–S29
  3. Lowrie EG , Lew NL . Death risk in hemodialysis patients (The predictive value of commonly measured variables and an evaluation of death rate differences between facilities) . Am J Kidney Dis . 1990;15:458–482
  4. Block GA , Hulbert-Shearon TE , Levin NW , et al.   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients (A national study) . Am J Kidney Dis . 1998;31:607–617
  5. Ganesh SK , Stack AG , Levin NW , et al.   Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients . J Am Soc Nephrol . 2001;12:2131–2138
  6. Kurz P , Monier-Faugere MC , Bognar B , et al.   Evidence for abnormal calcium homeostasis in patients with adynamic bone disease . Kidney Int . 1994;46:855–861
  7. Meric F , Yap P , Bia MJ . Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy . Am J Kidney Dis . 1990;16:459–464
  8. Sperschneider H , Gunther K , Marzoll I , et al.   Calcium carbonate (CaCO3) (An efficient and safe phosphate binder in haemodialysis patients? A 3-year study) . Nephrol Dial Transplant . 1993;8:530–534
  9. Bleyer AJ , Burke SK , Dillon M , et al.   A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients . Am J Kidney Dis . 1999;33:694–701
  10. Coburn JW , Hartenbower DL , Massry SG . Intestinal absorption of calcium and the effect of renal insufficiency . Kidney Int . 1973;4:96–104
  11. Hou SH , Zhao J , Ellman CF , et al.   Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate . Am J Kidney Dis . 1991;18:217–224
  12. Hsu CH . Are we mismanaging calcium and phosphate metabolism in renal failure? . Am J Kidney Dis . 1997;29:641–649
  13. Teng M , Wolf M , Lowrie E , et al.   Survival of patients undergoing hemodialysis with paricalcitrol or calcitriol therapy . N Engl J Med . 2003;349:446–456
  14. Kuzela DC , Huffer WE , Conger JD , et al.   Soft tissue calcification in chronic dialysis patients . Am J Pathol . 1977;86:403–424
  15. Braun J , Oldendorf M , Moshage W , et al.   Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients . Am J Kidney Dis . 1996;27:394–401
  16. Rumberger JA , Brundage BH , Rader DJ , et al.   Electron beam computed tomographic coronary calcium scanning (A review and guidelines for use in asymptomatic persons) . Mayo Clin Proc . 1999;74:243–252
  17. Kimura K , Saika Y , Otani H , et al.   Factors associated with calcification of the abdominal aorta in hemodialysis patients . Kidney Int Suppl . 1999;71:S238–S241
  18. Goodman WG , Goldin J , Kuizon BD , et al.   Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis . N Engl J Med . 2000;342:1478–1483
  19. Raggi P , Boulay A , Chasan-Taber S , et al.   Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? . J Am Coll Cardiol . 2002;39:695–701
  20. Tamashiro M , Iseki K , Sunagawa O , et al.   Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis . Am J Kidney Dis . 2001;38:64–69
  21. Guerin AP , London GM , Marchais SJ , et al.   Arterial stiffening and vascular calcifications in end-stage renal disease . Nephrol Dial Transplant . 2000;15:1014–1021
  22. Blacher J , Guerin AP , Pannier B , et al.   Impact of aortic stiffness on survival in end-stage renal disease . Circulation . 1999;99:2434–2439
  23. Blacher J , Guerin AP , Pannier B , et al.   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease . Hypertension . 2001;38:938–942
  24. London GM , Guerin AP , Marchais SJ , et al.   Arterial media calcification in end-stage renal disease (Impact on all-cause and cardiovascular mortality) . Nephrol Dial Transplant . 2003;18:1731–1740
  25. Chertow GM , Burke SK , Raggi P  Treat to Goal Working Group . Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients . Kidney Int . 2002;62:245–252
  26. Chertow GM , Raggi P , McCarthy JT , et al.   The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients . Am J Nephrol . 2003;23:307–314

PII: S0270-9295(04)00086-5

doi: 10.1016/j.semnephrol.2004.06.003

Seminars in Nephrology
Volume 24, Issue 5 , Pages 403-407 , September 2004

Article Tools